CD79A and nasopharyngeal carcinoma: In studies carried out in NPC endemic areas, the titer of anti-EBV IgA targeting reactivation antigens (such as VCA) has been shown to correlate with an increased risk of progression to NPC [30–33] and reviewed in [34].